Top‐line data from a phase 1b biomarker‐directed, proof of biology study in Alzheimer's patients treated with XPRO1595, a second‐generation treatment for immune dysfunction
Epidemiology Health Policy Inflammation Biology Immune Dysfunction Psychiatry and Mental health Cellular and Molecular Neuroscience Developmental Neuroscience medicine Cancer research Biomarker (medicine) Neurology (clinical) Geriatrics and Gerontology medicine.symptom